Detalhe da pesquisa
1.
Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
J Immunol
; 194(1): 101-12, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416804
2.
Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors.
J Immunol
; 182(9): 5400-11, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19380787
3.
Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells.
Clin Cancer Res
; 13(16): 4920-7, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17699872
4.
Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes.
Int Immunopharmacol
; 38: 223-32, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27302770
5.
Identification and quantitation of gamma-hydroxybutyrate (NaGHB) by nuclear magnetic resonance spectroscopy.
J Forensic Sci
; 48(2): 292-8, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12664985
6.
Preclinical assessment of curcumin as a potential therapy for B-CLL.
Am J Hematol
; 82(1): 23-30, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16947318
7.
CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
J Biol Chem
; 282(24): 17475-85, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17446175
8.
Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
Cytokine
; 35(5-6): 235-46, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17052915